IMPORTANT SAFETY INFORMATION
The MyoSure® tissue removal system is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including submucous myomas, endometrial polyps, and retained products of conception. It is not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies, or previously diagnosed endometrial cancer. |
|
|
|
REFERENCE: Vaishali Bhalani, M.D., Andrew Chang, M.D., Christen Adkins, M.D., Serena H. Chen, M.D., and Michael Scheiber, M.D., M.P.H. Fertility outcomes after hysteroscopic morcellation of intrauterine leiomyomas and polyps. J Reprod Med. 2016;61(4):327-335.
EMB-00892-001 ©2017 Hologic, Inc. Hologic, MyoSure, The Science of Sure, and associated logos are trademarks or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. |
|
|
|